These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27083518)

  • 1. Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
    Iguchi M; Kato J; Yoshida T; Yamamoto Y; Nakachi K; Fukatsu K; Mori Y; Maeda Y; Moribata K; Shingaki N; Niwa T; Deguchi H; Inoue I; Maekita T; Tamai H; Ichinose M
    Int J Cancer; 2016 Sep; 139(5):1150-6. PubMed ID: 27083518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
    Kwon Y; Jeon S; Nam S; Shin I
    Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
    Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
    Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between
    Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
    World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
    Yanaoka K; Oka M; Ohata H; Yoshimura N; Deguchi H; Mukoubayashi C; Enomoto S; Inoue I; Iguchi M; Maekita T; Ueda K; Utsunomiya H; Tamai H; Fujishiro M; Iwane M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2009 Dec; 125(11):2697-703. PubMed ID: 19610064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.
    Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T
    Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
    Boda T; Ito M; Yoshihara M; Kitamura Y; Matsuo T; Oka S; Tanaka S; Chayama K
    Helicobacter; 2014 Feb; 19(1):1-8. PubMed ID: 24215601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
    Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
    Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.
    Kim YI; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Ryu KW; Kim YW
    Helicobacter; 2014 Jun; 19(3):194-201. PubMed ID: 24612125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.
    Bae SE; Jung HY; Kang J; Park YS; Baek S; Jung JH; Choi JY; Kim MY; Ahn JY; Choi KS; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Am J Gastroenterol; 2014 Jan; 109(1):60-7. PubMed ID: 24343545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication.
    Shiotani A; Uedo N; Iishi H; Yoshiyuki Y; Ishii M; Manabe N; Kamada T; Kusunoki H; Hata J; Haruma K
    Digestion; 2008; 78(2-3):113-9. PubMed ID: 19023205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer.
    Nam SY; Jeon SW; Lee HS; Kwon YH; Park H; Choi JW
    Dig Liver Dis; 2017 May; 49(5):500-506. PubMed ID: 28057446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
    Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
    Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis.
    Jung DH; Kim JH; Chung HS; Park JC; Shin SK; Lee SK; Lee YC
    PLoS One; 2015; 10(4):e0124725. PubMed ID: 25915048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.